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a b s t r a c t
Cardiac resynchronization therapy with an implantable cardioverter-deﬁbrillator (CRT-D) is the preferred
treatment for patients with severe heart failure, dyssynchrony, and an increased risk of sudden cardiac
death or for primary ventricular arrhythmia survivors. Rarely, left ventricular epicardial pacing can induce
ventricular tachyarrhythmia rather than a beneﬁcial effect. We describe an ischemic cardiomyopathy
patient who underwent CRT-D therapy and developed sustained torsades de pointes (TdP) immediately
after switching to biventricular pacing (BVP) mode. Here, TdP possibly developed owing to the change in
the dispersion of repolarization of the left ventricle myocardium. The diagnosis and management of BVP-
induced ventricular arrhythmia is discussed.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Several randomized trials have shown that cardiac resynchro-
nization therapy (CRT) improves exercise capacity, quality of life,
and functional class in patients with severe drug-refractory con-
gestive heart failure (CHF) caused by left ventricular (LV) dysfunc-
tion and electrical dyssynchrony [1]. The combination of CRT and
an implantable cardioverter-deﬁbrillator (ICD) is the preferred
treatment for patients with severe heart failure, dyssynchrony,
and an increased risk of sudden cardiac death or for survivors of a
primary ventricular arrhythmia episode. Though it produces
satisfactory improvements in hemodynamic parameters, func-
tional class, and exercise capacity, the anti-arrhythmic effect of
CRT therapy is not well established. Some studies have shown
that biventricular pacing (BVP) is associated with a decrease
in the incidence or excitability of monomorphic ventricular
tachycardia (MMVT) [2–4], while others demonstrated a pro-
arrhythmic potential [5–7].
Here, we present a patient with ischemic cardiomyopathy who
underwent CRT-D implantation and developed sustained torsades
de pointes (TdP) immediately after switching to BVP mode. In this
case, the development of TdP was possibly due to the change in
the dispersion of repolarization of the left ventricle myocardium.
2. Case report
A 59-year-old woman with a previous high lateral myocardial
infarction and ischemic cardiomyopathy was admitted to our
institution several times owing to heart failure decompensation.
Coronary angiography performed after she suffered a transmural
myocardial infarction in 2008 revealed 30–40% diffuse athero-
sclerotic plaque after the ﬁrst septal branch of the left anterior
descending (LAD) artery and subtotal stenosis of the ﬁrst diagonal
with a small calibration. The right coronary and circumﬂex arteries
were found to be normal. At this time, her ejection fraction was
40% with LV anterior wall hypokinesis and moderate mitral
regurgitation on transthoracic echocardiography. In 2011, gated
myocardial perfusion scintigraphy (TC-99m MIBI) revealed a small
ischemic area near the apex and a ﬁxed perfusion defect consistent
with a transmural myocardial infarction at the anterior wall
segment from the mid-ventricle to the base and at the anterior-
lateral wall segment of the LV mid-ventricle with an ejection
fraction of 35%. The patient's condition worsened over time, with
her New York Heart Association (NYHA) functional class increasing
from I to III. In 2013, cardiac resynchronization therapy was
considered after three admissions for acute heart failure decom-
pensation. At this time, her electrocardiogram (ECG) showed a QRS
duration of 160 ms with an LBBB morphology and sinus rhythm
(Fig. 1). The LV ejection fraction decreased to 20% with global
akinesis, and severe mitral and tricuspid regurgitation was present
at the time of intervention. ICD combined with CRT was the
preferred method for primary prevention as there were no prior
episodes of syncope and tachycardia.
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Implantation of the LV lead of the CRT-D into the posterior-
lateral branch of the coronary sinus was performed successfully.
After the activation of the BVP mode in the operating room, an
incessant electrical storm of TdP commenced. After three anti-
tachycardia pacing (ATP) attempts, deﬁbrillation occurred and the
tachycardia started repeatedly. Each TdP episode was stopped by
device deﬁbrillation (Fig. 2). As there was no history of ventricular
tachycardia (VT) since the start of heart failure, it appeared that
the tachycardia was associated with the ventricular pacing mode,
and the BVP mode was stopped. Owing to the patient's instability,
we could not perform echocardiography under the BVP mode and
LV pacing mode. Every pacing attempt with these modes resulted
in TdP, and accordingly the device was switched off. All electrolyte
levels were in the normal range before and after the operation.
After two days without any tachycardia episode, the BVP mode
was reactivated in the coronary care unit and tachycardia started
again. Atrial and ventricular pacing was re-attempted, and VT
started after LV pacing. No tachycardia was detected with right
ventricular pacing and atrial pacing. The patient was observed in
the hospital for another seven days with the device switched off
and no tachycardia occurred. The patient was discharged under
oral treatment with amiodarone 200 mg twice daily.
A repositioning of another lead to a different branch of the
coronary sinus vein was planned, but the patient refused.
3. Discussion
CRT has become an established adjunctive treatment to optimal
pharmacological therapy in patients with advanced CHF, dimin-
ished LV function, and intra-ventricular conduction delay [8].
Despite the beneﬁts of CRT including improvements in exercise
capacity, functional class, and ventricular hemodynamics, a pro-
arrhythmic effect is less clear. The incidence of pro-arrhythmia
reported in a limited single series was low, ranging from 3.4% to 4%
during the ﬁrst few days, with a predominance for ischemic
cardiomyopathy patients [7–9]. Tachyarrhythmia was observed
as MMVT, mostly in ischemic cardiomyopathy patients, or as
Fig. 1. A baseline ECG shows normal sinus rhythm and an LBBB morphology with a QRS duration of 160 ms.
Fig. 2. Intracardiac electrograms show multiple ventricular ﬁbrillations and deﬁbrillations.
Fig. 3. The ICD event recorder has recorded multiple ventricular ﬁbrillations and deﬁbrillations.
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polymorphic ventricular tachycardia (PMVT) or TdP, as seen in
our case.
Most MMVTs seen in ischemic cardiomyopathy patients are
caused by reentry and involve complex circuits in the LV [10]. The
induction of a reentrant VT may be site speciﬁc, and can be
facilitated by pacing at or near these circuits [11]. Reentry is the
mechanism responsible for MMVT in CRT-implanted patients.
Normally, ventricular activation starts at the endocardium via
the subendocardial Purkinje network and spreads across the
ventricular wall. Although the epicardium is activated last, it
repolarizes ﬁrst because of its shorter action potential duration.
This produces a repolarization sequence opposite to activation
[12]. On ECG, this activation and repolarization sequence produces
an upright T wave with the same polarity as the QRS [12]. LV
epicardial pacing via the coronary sinus route abolishes normal
repolarization of the LV by prolonging the QT interval, JT interval,
and transmural dispersion of repolarization. First deﬁned in 2003
by Medina-Ravell et al. [5], pacing site-dependent changes in
ventricular repolarization potentially constitute the mechanism
of TdP. Prolongation of ventricular repolarization time, the same
circumstance as in long QT syndromes, makes the ventricle
vulnerable to ventricular extrasystoles that result in R on T
phenomenon and TdP. With BVP mode, the patient's QTc interval
was prolonged from 521 ms to 536 ms, the JTc interval was
prolonged from 305 ms to 360 ms, and the T peak–T end interval
was prolonged from 120 ms to 190 ms. All markers of myocardial
dispersion of repolarization were prolonged with LV epicardial
pacing, and BVP was followed by ventricular extrasystole over the
T wave resulting in TdP. Despite amiodarone infusion, 12 appro-
priate CRT-D deﬁbrillations occurred (Fig. 3). As noted above,
switching off the BVP mode stopped the electrical storm of TdP.
4. Conclusion
CRT can complicate incessant ventricular arrhythmia that may
be resistant to medical therapy and therefore endanger the
patient's life. In such situations, the BVP mode should be switched
off and the LV pacing mode will usually terminate tachyarrhyth-
mia. Reentry is thought to be the main mechanism of MMVT while
LV repolarization dispersion is thought to be the mechanism of
PMVT and TdP. Patients with a long QT, long JT, and T wave
dispersion on initial ECG who have undergone CRT without an ICD
are at an increased risk of sudden cardiac death. Luckily, CRT-D
was present in our patient and the ICD saved her life. This clearly
shows that CRT can induce ventricular arrhythmias and implies
the need for CRT to systematically be associated with a deﬁbrilla-
tion system.
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